院内心脏骤停前预测良好神经功能生存:PIHCA评分
该研究基于GO-FAR评分外部验证的717例成人院内心脏骤停,重新定义和精简预测因子并加入慢性合并症,构建9个预测因子的PIHCA评分。结局为出院时脑功能分类评分1-2分的良好神经功能生存,按可能性分为极低(<1%)、低(1-3%)和高于低(>3%)。模型AUROC为0.808(95%CI 0.807-0.810),校准满意;以3%为界值敏感性99.4%、特异性8.4%,归入≤3%可能性的预测值高(97.4%),错误归入≤3%的可能性低(0.6%)。作者认为PIHCA评分有潜力作为院内心脏骤停后结局的客观预测工具,作为DNAR决策过程的一部分。
要点
- PIHCA评分用于院内心脏骤停前预测良好神经功能生存,结局定义为出院时脑功能分类评分1-2分。
- 预测可能性分为极低(<1%)、低(1-3%)和高于低(>3%)三档。
- 以3%为界值,敏感性99.4%、特异性8.4%,归入≤3%可能性的预测值高(97.4%),错误归入≤3%的可能性低(0.6%)。
- 模型AUROC为0.808(95%CI 0.807-0.810),校准满意。
- 作者认为该评分有潜力作为DNAR决策过程中的客观工具之一。
适用人群与场景
- 成人院内心脏骤停(IHCA)患者,基于717例成人IHCA进行模型开发。
诊断标准与关键阈值
- 良好神经功能生存定义为出院时脑功能分类(CPC)评分1-2分。
- 预测良好神经功能生存可能性分为极低(<1%)、低(1-3%)和高于低(>3%),以3%为界值。
研究设计与关键结果
- 研究基于GO-FAR评分的外部验证,纳入717例成人IHCA,重新定义和精简预测因子并加入慢性合并症,构建含9个预测因子的PIHCA评分。
- 模型AUROC为0.808(95%CI 0.807-0.810),校准满意。
- 以3%为界值,敏感性99.4%、特异性8.4%。
- 归入≤3%可能性的预测值高(97.4%),错误归入≤3%的可能性低(0.6%)。
证据类型、等级与局限
- 证据类型:预测模型开发研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为PIHCA评分有潜力作为院内心脏骤停前预测结局的客观工具,作为DNAR决策过程的一部分。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: A prearrest prediction tool can aid clinicians in consolidating objective findings with clinical judgement and in balance with the values of the patient be a part of the decision process for do-not-attempt-resuscitation (DNAR) orders. A previous prearrest prediction tool for in-hospital cardiac arrest (IHCA) have not performed satisfactory in external validation in a Swedish cohort. Therefore our aim was to develop a prediction model for the Swedish setting.
METHODS: Model development was based on previous external validation of The Good Outcome Following Attempted Resuscitation (GO-FAR) score, with 717 adult IHCAs. It included redefinition and reduction of predictors, and addition of chronic comorbidity, to create a full model of 9 predictors. Outcome was favourable neurological survival defined as Cerebral Performance Category score 1-2 at discharge. The likelihood of favourable neurological survival was categorised into very low (<1%), low (1-3%) and above low (>3%).
RESULTS: We called the model the Prediction of outcome for In-Hospital Cardiac Arrest (PIHCA) score. The AUROC was 0.808 (95% CI 0.807-0.810) and calibration was satisfactory. With a cutoff of 3% likelihood of favourable neurological survival sensitivity was 99.4% and specificity 8.4%. Although specificity was limited, predictive value for classification into ≤3% likelihood of favorable neurological survival was high (97.4%) and false classification into ≤3% likelihood of favourable neurological survival was low (0.6%).
CONCLUSION: The PIHCA score has the potential to be used as an objective tool in prearrest prediction of outcome after IHCA, as part of the decision process for a DNAR order.
参考来源
- Piscator E, Göransson K, Forsberg S, et al. Prearrest prediction of favourable neurological survival following in-hospital cardiac arrest: The Prediction of outcome for In-Hospital Cardiac Arrest (PIHCA) score. Resuscitation. 2019. PMID: 31412292. doi:10.1016/j.resuscitation.2019.08.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。